On Demand Treatment of Reflux Disease

Norwegian University of Science and Technology82 enrolled

Overview

A comparison of the effect of on demand treatment with a pectin-containing natural product (Aflurax) with that esomeprazole (Nexium)

A randomized, controlled, open trial comparing the symptomatic effect of a pectin-containing product (Aflurax) with that of esomeprazole (Nexium 20 mg) given on-demand for 6 weeks.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Gastroesophageal Reflux

Interventions

AfluraxDRUG

esomeprazoleDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Mild and moderate reflux symptoms Age \> 17 years Informed consent - Exclusion Criteria: Other conditions that might explain the symptoms Abuse of drugs or alcohol \-

Locations (9)

Gjøvik Specialist Centre

Gjøvik, Norway

Sykehuset Innlandet HF, Gjøvik

Gjøvik, Norway

Sykehuset Innlandet HF, Hamar

Hamar, Norway

Sykehuset Innlandet HF, Kongsvinger

Kongsvinger, Norway

Outcomes

Primary Outcomes

Symptomatic relief

Secondary Outcomes

Overall satisfaction

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.